EP1833791
2,3,4,9-Tetrahýdró-1H-karbasól afleiður sem CRTH2 viðtakamótlyf.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
22.12.2005EP published:
3.8.2011EP application number:
05850906.8
EP translation filed:
4.10.2011Grant published:
15.10.2011EPO information:
European Patent Register
Max expiry date:
21.12.2025Expiry date:
21.12.2013
Title:
2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS
Timeline
Today
22.12.2005EP application
3.8.2011EP Publication
4.10.2011Translation submitted
15.10.2011Registration published
21.12.2013Expires
Owner
Name:
Actelion Pharmaceuticals Ltd.Address:
Gewerbestrasse 16, 4123, Allschwil, CH
Inventor
Name:
FECHER, AnjaAddress:
Allschwil, CH
Name:
FRETZ, HeinzAddress:
Riehen, CH
Name:
RIEDERER, MarkusAddress:
Liestal, CH
Agent
Name:
Reynaldsson Patent ConsultingAddress:
Pósthólf 48, 212, Garðabæ,
Priority
Number:
PCT/EP2004/014719Date:
27.12.2004Country:
WO
Classification
Categories:
C07D 209/88, A61K 31/404, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 18.11.2011
Expires: 21.12.2012
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 20.11.2012
Expires: 21.12.2013
Payer: G. H. Sigurgeirsson